We are live on !
Find out more
BCM
Bayesian Capital Management Portfolio holdings
AUM
$156M
Turnover
90.24%
1-Year Est. Return
14.89%
This Fund
S&P 500
This Quarter Est. Return
+7.46%
1 Year Est. Return
+14.89%
3 Year Est. Return
+106.87%
5 Year Est. Return
+133.82%
10 Year Est. Return
+1,146.1%
AUM
$156M
AUM Growth
+$74.4M
(+91%)
Cap. Flow
+$78.8M
Cap. Flow % of AUM
Cap. Flow %
50.43%
Top 10 Holdings %
Top 10 Hldgs %
25.26%
Holding
328
New
191
Increased
20
Reduced
12
Closed
105
Avg Time Held
0
years
Top 10 Avg Time Held
0.1
years
Top 20 Avg Time Held
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$8.52M |
| 2 |
NVIDIA
NVDA
|
+$6.41M |
| 3 |
Oracle
ORCL
|
+$5.76M |
| 4 |
Microsoft
MSFT
|
+$3.56M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$3.44M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sandisk
SNDK
|
+$5.33M |
| 2 |
ExxonMobil
XOM
|
+$2.87M |
| 3 |
Meta Platforms (Facebook)
META
|
+$2.69M |
| 4 |
Rocket Lab Corp
RKLB
|
+$2.61M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$2.54M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.57% |
| 2 | Consumer Discretionary | 16.88% |
| 3 | Financials | 11.54% |
| 4 | Healthcare | 9.13% |
| 5 | Materials | 6.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
226
Archer Daniels Midland
ADM
$37.1B
| – | – |
-3,862
| Closed | -$281K | – |
|
227
ADMA Biologics
ADMA
$2.56B
| – | – |
-47,700
| Closed | -$430K | – |
|
228
Adaptive Biotechnologies
ADPT
$4.25B
| – | – |
-19,485
| Closed | -$270K | – |
|
229
Affirm
AFRM
$24.8B
| – | – |
-4,500
| Closed | -$206K | – |
|
230
AGNC Investment
AGNC
$11B
| – | – |
-64,600
| Closed | -$648K | – |
|
231
Argan
AGX
$4.83B
| – | – |
-843
| Closed | -$459K | – |
|
232
American International
AIG
$42.8B
| – | – |
-10,897
| Closed | -$820K | – |
|
233
Amkor Technology
AMKR
$9.8B
| – | – |
-6,199
| Closed | -$279K | – |
|
234
Arista Networks
ANET
$213B
| – | – |
-2,030
| Closed | -$249K | – |
|
235
Amphenol
APH
$196B
| – | – |
-19,202
| Closed | -$1.21M | – |
|
236
DELISTED
Apellis Pharmaceuticals
APLS
| – | – |
-13,104
| Closed | -$527K | – |
|
237
Arm
ARM
$220B
| – | – |
-3,623
| Closed | -$548K | – |
|
238
AST SpaceMobile
ASTS
$12.3B
| – | – |
-8,587
| Closed | -$712K | – |
|
239
Banco Bilbao Vizcaya Argentaria
BBVA
$134B
| – | – |
-13,000
| Closed | -$282K | – |
|
240
Bumble
BMBL
$800M
| – | – |
-14,400
| Closed | -$46.9K | – |
|
241
BP
BP
$130B
| – | – |
-7,300
| Closed | -$343K | – |
|
242
Conagra Brands
CAG
$6.96B
| – | – |
-88,200
| Closed | -$1.39M | – |
|
243
Crown Castle
CCI
$37.7B
| – | – |
-6,148
| Closed | -$500K | – |
|
244
Celsius Holdings
CELH
$7.37B
| – | – |
-17,700
| Closed | -$628K | – |
|
245
Chewy
CHWY
$8.56B
| – | – |
-22,130
| Closed | -$598K | – |
|
246
Capital One
COF
$126B
| – | – |
-2,850
| Closed | -$520K | – |
|
247
Americold
COLD
$4.1B
| – | – |
-33,335
| Closed | -$382K | – |
|
248
CRH
CRH
$60.4B
| – | – |
-2,900
| Closed | -$305K | – |
|
249
CoStar Group
CSGP
$12.1B
| – | – |
-8,100
| Closed | -$327K | – |
|
250
CVS Health
CVS
$115B
| – | – |
-2,801
| Closed | -$201K | – |
|
Similar funds
HSM
APW
Bayesian Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Bayesian Capital Management held 328 positions worth $156M, up 91% from $81.9M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Bayesian Capital Management deployed $78.8M of net new capital in Q2 2026, opening 191 new positions and adding to 20 existing holdings. Its largest new stake was Alibaba: 67,999 shares worth $6.53M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Sandisk, an estimated $5.33M trimmed.
- Bayesian Capital Management's largest Q2 2026 buy was Alibaba: 67,999 shares worth $6.53M.
- Bayesian Capital Management added most to Oracle in Q2 2026, an estimated $5.76M increase.
- Bayesian Capital Management's biggest Q2 2026 reduction was Sandisk, cutting an estimated $5.33M.
- Bayesian Capital Management fully exited ExxonMobil in Q2 2026, selling an estimated $2.87M.
- Bayesian Capital Management's ten largest holdings make up 25% of its $156M portfolio in Q2 2026.
- Bayesian Capital Management opened 191 new positions and closed 105 in Q2 2026.
- Bayesian Capital Management's portfolio value rose 91% quarter-over-quarter to $156M.
Based on Bayesian Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.